Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
91-105 of 1467 results
ClearDATA, Liaison partner to expand cloud-based healthcare solutions
By PBR Staff Writer
ClearDATA Networks and Liaison Technologies have formed a strategic partnership to collaborate on solution offerings for new and existing healthcare clients.
Automation > IT & Software > News
Idera publish promising preclinical data targeting microRNA with gene silencing oligonucleotide technology
Idera Pharmaceuticals, a clinical-stage biopharmaceutical company developing nucleic acid therapeutics for patients with cancer and rare diseases, has announced the publication of promising preclinical data demonstrating the application of the Company’s novel Gene Silencing Oligonucleotides (GSOs) to inhibit microRNAs implicated in neovascularization, a process that involves the proliferation of blood vessels in tissue and is crucial for recovery following cardiovascular events.
Automation > IT & Software > News
Certara launches D360 in Japan to improve drug discovery and development productivity
Certara, the leading global technology-enabled drug development and drug safety consultancy, has announced the launch in Japan of D360, its integrated solution for the query, analysis and visualization of drug discovery and development data.
Automation > IT & Software > News
Kadimastem to collaborate with Merck Serono to advance combined efforts in neurodegenerative disease area
Israeli biotechnology company Kadimastem reports that it has signed a collaboration agreement with Merck to carry out drug screening in the neurodegenerative diseases space for multiple sclerosis (MS), and potential other neurodegenerative diseases.
Automation > IT & Software > News
US Patent Office grants Notice of Allowance to Mystic for powder drug delivery technology
By PBR Staff Writer
US-based Mystic Pharmaceuticals has received a Notice of Allowance from the US Patent Office for its 'Medical Devices For Dispensing Powders'.
Automation > IT & Software > News
Catylix, Aspira Scientific form joint venture to commercialize new fluorination technologies
Catylix and Aspira Scientific have announced the formation of a joint venture to develop and commercialize new fluorination products and related chemistry.
Automation > IT & Software > News
Transgenomic announces issuance of new European patent covering COLD-PCR technologies
Transgenomic, a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, has announced that the European Patent Office has issued a new patent, European Patent No. 21833798, covering one of its COLD-PCR family of DNA amplification technologies.
Automation > IT & Software > News
Theraclone enters into agreement with Gilead Sciences for broadly neutralizing HIV antibodies
Theraclone Sciences, a therapeutic antibody discovery and development company, announced today that it has entered into an agreement with Gilead Sciences under which Gilead received an exclusive license to develop and commercialize products incorporating Theraclone’s broadly neutralizing HIV-antibodies for therapeutic applications in HIV.
Automation > IT & Software > News
Cellectis sells Swedish subsidiary Cellectis to Takara Bio
Cellectis, a leader in the development of adoptive immunotherapies based on engineered allogeneic CART cells (UCART) has announced the sale of its subsidiary Cellectis AB to the Japanese Company Takara Bio.
Automation > IT & Software > News
EastGate expands pharmaceutical developments with sub-micron platform technology
EastGate Acquisitions, an emerging pharmaceutical company exploring drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules has announced expansion of its pharmaceutical development implementing its sub-micron platform technology.
Automation > IT & Software > News
Advaxis receives notice of allowance for cancer immunotherapies patent in Japan
Advaxis, a biotechnology company developing the next generation of cancer immunotherapies, has received a notice of allowance from the Japan Patent Office for a patent application related to the Advaxis proprietary Lm-LLO cancer immunotherapy platform technology
Automation > IT & Software > News
Lion, Moffitt Cancer Center partner to improve tumor infiltrating lymphocyte production
By PBR Staff Writer
Lion Biotechnologies that develops new cancer immunotherapies based on tumor infiltrating lymphocytes (TILs) has entered into an exclusive, worldwide license agreement with Moffitt Cancer Center.
Automation > IT & Software > News
biOasis releases quantitative results: siRNA-Transcendpep reduces target gene expression in the brain
BIOASIS TECHNOLOGIES, a pioneering biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier (BBB), has announced on May 6th, 2014, that its newly discovered carrier peptide-Transcendpep-effectively delivered siRNA across the BBB and into brain cells.
Automation > IT & Software > News
TransCelerate selects Cognizant to develop a clinical trials collaboration platform
Cognizant has announced that it has been selected by TransCelerate BioPharma, a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a first-of-its-kind, subscription-based platform that will transform the way clinical sites collaborate with pharmaceutical companies on clinical trials.
Automation > IT & Software > News
MYOS gets notice of allowance of US Patent Application for manufacturing methods of Fortetropin
MYOS, an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve muscle health and performance, has recently received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for U.S. Patent Application Serial No. 13/765,340 covering the Company's proprietary methods of manufacturing Fortetropin, the first clinically proven natural myostatin inhibitor.
Automation > IT & Software > News
91-105 of 1467 results